Ancestim biosimilar - Profarma

Drug Profile

Ancestim biosimilar - Profarma

Alternative Names: PF-09; Recombinant human stem cell factor - Profarma; Recombinant SCF - Profarma

Latest Information Update: 26 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Profarma
  • Class Antianaemics; Antineoplastics; Stem cell factors
  • Mechanism of Action Colony stimulating factor stimulants; Stem cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Cancer

Most Recent Events

  • 17 Jun 2015 Early research in Cancer in Lithuania (Parenteral) (Profarma pipeline, June 2015)
  • 02 Apr 2015 Profarma has patent protection for ancestim biosimilar (Profarma website, June 2015)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top